HAMBURG, Germany – Version two of the Freestyle Libre portable glucose measuring device, aptly named Freestyle Libre 2, will soon be available for people in Europe with diabetes after the product received CE declaration of conformity to be sold in Europe.

HAMBURG, Germany – Diagnostics, applied testing and pharmaceutical research company Qiagen NV applauded a UN initiative finalized last week that in coming years will massively increase global efforts to fight tuberculosis (TB), with the goal to end TB by 2030.

HAMBURG, Germany – U.K. firm Cellesce Ltd., based in Cardiff, Wales, will be collaborating during the next 12 months with the U.K. National Physical Laboratory to document the company's full range of colorectal cancer organoids, which could contribute to the development of an international imaging standard for organoid analysis.